BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
351 hedge funds and large institutions have $8.24B invested in Blueprint Medicines in 2025 Q2 according to their latest regulatory filings, with 110 funds opening new positions, 94 increasing their positions, 116 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7.62% less ownership
Funds ownership: 107.21% → 99.58% (-7.6%)
19% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 116
32% less call options, than puts
Call options by funds: $144M | Put options by funds: $210M
Holders
351
Holding in Top 10
29
Calls
$144M
Puts
$210M
Top Buyers
| 1 | +$500M | |
| 2 | +$250M | |
| 3 | +$226M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$218M |
| 5 |
Barclays
London,
United Kingdom
|
+$183M |
Top Sellers
| 1 | -$506M | |
| 2 | -$445M | |
| 3 | -$338M | |
| 4 |
JP Morgan Chase
New York
|
-$268M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$182M |
